Cell-therapy translation platform of the State Key Laboratory of Biotherapy
2016–Relying on the State Key Laboratory of Biotherapy, it conducts CAR-T and cancer vaccine research, forming the largest tumor biotherapy R&D base in western China.

Grade III-A · National Comprehensive Medical Center
Established
1892
Beds
4,300+
Annual Volume
5,000,000+
Chengdu
The leading medical hub of Western China with top-tier comprehensive cancer care and translational research.
West China Hospital of Sichuan University is the national center for complex and critical care in western China, ranking second nationally in the Fudan comprehensive hospital ranking for many consecutive years. Its cancer center leverages the hospital’s comprehensive strength, excelling in multidisciplinary collaboration and comorbidity management for complex tumors.
West China leads nationally in minimally invasive surgery, precision radiotherapy and translational research for lung, esophageal, head-neck and abdominal tumors, and is one of the National Clinical Research Centers for Cancer.
01Comprehensive strength for complex cases
Cancer patients with cardiopulmonary disease, diabetes and other comorbidities receive hospital-wide MDT support, with nationally leading perioperative safety.
02Largest radiotherapy center in western China
Equipped with multiple linacs, TOMO and brachytherapy systems, it treats the largest annual radiotherapy volume in western China.
03The western hub for clinical research
As a national drug clinical-trial institution, it hosts numerous international multicenter studies and is the main gateway for western-China patients to frontier research.
Relying on the State Key Laboratory of Biotherapy, it conducts CAR-T and cancer vaccine research, forming the largest tumor biotherapy R&D base in western China.
As an exporting hospital of the national regional cancer care center, it exports technology and management to western provinces, building a specialty alliance and two-way referral network covering the region.